Sort
21,281 grants matching “influenza”
Detrimental Effects of B-Cell-Th17 Axis in Antiviral Immunity in Smokers.
$799,998Farrah Kheradmand · Baylor College Of Medicine · R01 · FY2025 · HL
US Influenza Vaccine Effectiveness Network
$799,995Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2019 · IP
Study of Influenza Incidence, Diagnosis, Treatment Efficacy, Vaccine Effectivenes
$799,929Nestor Sosa · Gorgas Memorial Institute Of Health St · U01 · FY2016 · IP
Determinants of Functional Immune Defects in Treated HIV Infection and Aging
$799,919Peter W Hunt · University Of California, San Francisco · R01 · FY2015 · AI
Non-inferiority study of adjuvanted vs. high dose flu vaccine in residents of long term care
$799,912David H Canaday · Case Western Reserve University · R01 · FY2018 · AI
Immunogenetics of COVID-19 Immune Response
$799,523Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2025 · AI
A Novel Live Non-replicating Universal Vaccine for Influenza
$799,507Sally R. Sarawar · Biomedical Research Instit/ Southern, Ca · R01 · FY2015 · AI
THE HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI) OUTBREAK IN U.S. DAIRY CATTLE IS A MAJOR THREAT TO U.S. CATTLE PRODUCERS, U.S. FOOD SECURITY, AND THE AGRICULTURAL SECTOR OF THE U.S. ECONOMY. THE OUTBREAK IS ESPECIALLY CHALLENGING BECAUSE IT IS THE FIRST TIME THAT HPAI HAS BEEN FOUND IN CATTLE. WE KNOW THAT SHIPMENTS OF DAIRY CATTLE HAVE MOVED HPAI OVER LONG DISTANCES BETWEEN STATES, BUT WE DON'T KNOW MUCH YET ABOUT HOW TO PREDICT OR STOP THE SPREAD. THE GOAL OF THIS PROJECT IS TO CREATE PREDICTIONS OF HOW HPAI COULD CONTINUE SPREADING ACROSS THE U.S. BASED ON CATTLE SHIPMENTS AND DISEASE DATA. WE HAVE THREE OBJECTIVES: 1) WE WILL COLLECT DATA ON CATTLE SHIPMENTS AND THE HPAI OUTBREAK; 2) WE WILL DEVELOP PREDICTIONS ABOUT U.S. CATTLE SHIPMENTS AND HPAI TRANSMISSION USING THE COLLECTED DATA (OBJ. 1) AND OTHER INFORMATION; 3) WE WILL USE THE HPAI DISEASE PREDICTIONS TO UNDERSTAND HOW HPAI IS SPREADING IN THE U.S. AND HOW IT CAN BE CONTROLLED. THIS PROJECT WILL GIVE US A WAY TO DETERMINE THE RISK OF HPAI SPREADING INTO NEW LOCATIONS IN THE U.S. AND WHAT CAN BE DONE TO PREVENT THAT SPREAD. WE WILL WORK WITH THE U.S. DEPARTMENT OF AGRICULTURE AND STATE VETERINARIANS TO ENSURE THAT THE RESULTS OF THIS PROJECT ARE USED TO HELP CREATE SURVEILLANCE AND RESPONSE STRATEGIES FOR HPAI. THE RESULTS OF THIS RESEARCH PROJECT WILL PROVIDE AN UNDERSTANDING OF THE ONGOING HPAI OUTBREAK AND WILL BE USED TO PROTECT THE INTERESTS OF INDIVIDUAL PRODUCERS AND THE CATTLE INDUSTRY IN GENERAL FROM THE IMPACTS OF HPAI OUTBREAKS NOW AND IN THE FUTURE.
$799,462Colorado State University · · FY2025 · National Institute of Food and Agriculture
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis
$799,386Shabaana A. Khader · Washington University · R01 · FY2020 · AI
Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic
$799,372Monica Gandhi · University Of California, San Francisco · R01 · FY2021 · AI
Patterning of Transcription Factor Activity in T cells During Influenza Infection
$799,293Rajat Varma · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
A systems immunology approach for predicting poor responses to Hepatitis B vaccination
$799,004Ramin Herati · New York University School Of Medicine · R01 · FY2025 · AI
Agonists of the RIG-I Innate Immune Pathway
$798,935Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2013 · AI
DEGRADATION OF RURAL HEALTHCARE SERVICES IN PANDEMIC INFLUENZA
$798,719Janet Archer · Indiana State Department Of Health · U90 · FY2008 · TP
Phase II Trial of H7N9 Influenza Vaccines - VTEU
$798,690Emmanuel B Walter · Duke University · N01 · FY2014 · AI
Ex vivo interrogation of the genetic and biochemical networks controlling influe
$798,687Megan Louise Shaw · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
Non-inferiority study of adjuvanted vs. high dose flu vaccine in residents of long term care
$798,632David H Canaday · Case Western Reserve University · R01 · FY2019 · AI
Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic
$798,527Monica Gandhi · University Of California, San Francisco · R01 · FY2023 · AI
Computational Modeling Core
$798,352Katrina M. Waters · University Of Wisconsin-Madison · U19 · FY2013 · AI
Prospective annual estimates of influenza vaccine effectiveness and burden of disease
$798,289Michael L Jackson · Kaiser Foundation Health Plan Of Washington · U01 · FY2016 · IP
Prospective annual estimates of influenza vaccine effectiveness and burden of disease
$798,289Michael L Jackson · Kaiser Foundation Research Institute · U01 · FY2017 · IP
Administrative Core
$798,118Monica Kraft · University Of Arizona · U19 · FY2024 · AI
Flu SAFE: Flu SMS Alerts to Freeze Exposure
$798,011Melissa S Stockwell · Columbia University Health Sciences · R01 · FY2017 · AI
Vaccine Development Of Nontypeable Haemophilus influenzae/Moraxella catarrhalis
$797,700Xin-Xing Xing Gu · National Institute On Deafness And Other Communication Disorders · Z01 · FY2008 · DC
Central role of Caspase-8 in control of host tolerance and resistance mechanisms in pulmonary macrophage populations during severe respiratory infections
$797,454Amanda M Jamieson · Brown University · R01 · FY2023 · HL